StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Hologic (HOLX) to Acquire Focal Therapeutics for $125 Million
September 26, 2018 4:02 PM
Hologic, Inc. (Nasdaq: HOLX), a global leader in women’s health, announced today that it has signed a definitive agreement to ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Corporate News
Management Comments
Mergers and Acquisitions
Next Articles
Hologic to Acquire Focal Therapeutics for $125 Million, Strengthening Breast Surgery Franchise
September 26, 2018 4:01 PM